Qi Chen Phones & Addresses
-
6220 Alder Dr, Houston, TX 77081
-
Hartford, CT
-
14221 51St Ave, Glendale, AZ 85306
-
15050 59Th Ave, Glendale, AZ 85306
-
Plano, TX
-
Naperville, IL
-
San Diego, CA
-
Las Vegas, NV
Resumes
Resumes
Qi Chen Chicago, IL
View pageWork:
Argosy University
2008 to 2000
Faculty
Argosy University
Chicago, IL
2010 to 2014
Area Library Director
Argosy University
Chicago, IL
1998 to 2010
Director of Library Services
Illinois School of Professional Psychology
Chicago, IL
1991 to 1998
Information Specialist / Instructional and Reference Librarian
2008 to 2000
Faculty
Argosy University
Chicago, IL
2010 to 2014
Area Library Director
Argosy University
Chicago, IL
1998 to 2010
Director of Library Services
Illinois School of Professional Psychology
Chicago, IL
1991 to 1998
Information Specialist / Instructional and Reference Librarian
Education:
Educational Leadership Argosy University Chicago
Chicago, IL
2006
Ed.D.
Dominican University
River Forest, IL
1996
Indiana State University
Terre Haute, IN
1991
M.Ed. in Curriculum and Instruction
Chicago, IL
2006
Ed.D.
Dominican University
River Forest, IL
1996
Indiana State University
Terre Haute, IN
1991
M.Ed. in Curriculum and Instruction
Skills:
Excellent skills in Computer/Microsoft Office Suite, Fluent in both Chinese and English in both speaking and writing, Excellent communication and interpersonal skills, Public speaking and presentation, Research and academic writing, Organizational skills.
Qi Chen Chandler, AZ
View pageWork:
Hengfa Shipping Company
Fujian, China
2008 to 2013
Chief Financial Officer
American Express
Phoenix, AZ
2007 to 2007
Financial Manager MBA Intern
Chinese Gourmet Restaurant
Chandler, AZ
1993 to 2005
Entrepreneur
Fujian, China
2008 to 2013
Chief Financial Officer
American Express
Phoenix, AZ
2007 to 2007
Financial Manager MBA Intern
Chinese Gourmet Restaurant
Chandler, AZ
1993 to 2005
Entrepreneur
Education:
W. P. Carey School of Business at Arizona State University
Tempe, AZ
May 2008
Master of Business Administration in Financial Management and Markets
Tempe, AZ
May 2008
Master of Business Administration in Financial Management and Markets
Skills:
Business Development and Financial Management
Business Records
Name / Title
Company / Classification
Phones & Addresses
President
L AND Z ENTERPRISE INC
Business Services
Business Services
2633 E Indian School Rd #370, Phoenix, AZ 85016
8510 W Coyote Dr, Peoria, AZ 85383
8510 W Coyote Dr, Peoria, AZ 85383
Director
ARIZONA DEVELOPMENT & MANAGEMENT LLC
2315 W Alamo Dr, Chandler, AZ 85224
Director 2315 W Alamo Dr, Chandler, AZ 85224
Director 2315 W Alamo Dr, Chandler, AZ 85224
Vice-President
BTIC AMERICA CORPORATION
Mfg Industrial Valves · Supplies Aluminum Cylinder and Cga Valves Regulators · Nonclassifiable Establishments
Mfg Industrial Valves · Supplies Aluminum Cylinder and Cga Valves Regulators · Nonclassifiable Establishments
6600 Sands Pt Dr STE 121, Houston, TX 77074
(713) 779-8882
(713) 779-8882
Manager
LIN LONG LLC
3507 W Dunlap Ave, Phoenix, AZ 85051
8510 W Coyote Dr, Peoria, AZ 85383
8510 W Coyote Dr, Peoria, AZ 85383
Secretary
GONG ENTERPRISE INC
1501 W Bethany Home Rd, Phoenix, AZ 85015
6737 Paljay Ct, Las Vegas, NV 89103
6737 Paljay Ct, Las Vegas, NV 89103
President/ceo
OSAKA STEAK HOUSE INC
Ctr Dr, Peoria, AZ 85382
8510 W Coyote Dr, Peoria, AZ 85383
8510 W Coyote Dr, Peoria, AZ 85383
Secretary, Director
SOFTWARE INTEGRATED CORPORATION
Whol Computers/Peripherals · Prepackaged Software Services · Computer Sales
Whol Computers/Peripherals · Prepackaged Software Services · Computer Sales
27911 Norfolk Trl Ln, Katy, TX 77494
2014 Edendale Cir, Katy, TX 77450
(281) 920-1088
2014 Edendale Cir, Katy, TX 77450
(281) 920-1088
OOKA HIBACHI GRILL LLC
Bldg BLDG B, Peoria, AZ 85382
8510 W Coyote Dr, Peoria, AZ 85383
8510 W Coyote Dr, Peoria, AZ 85383
Publications
Us Patents
Carboxylic Acid Derivatives That Inhibit The Binding Of Integrins To Their Receptors
View pageUS Patent:
7812038, Oct 12, 2010
Filed:
Jun 14, 2005
Appl. No.:
11/152695
Inventors:
Ronald J. Biediger - Houston TX, US
Qi Chen - Carmel IN, US
E. Radford Decker - Houston TX, US
George W. Holland - Houston TX, US
Jamal M. Kassir - Stafford TX, US
Wen Li - Pearland TX, US
Robert V. Market - Pearland TX, US
Ian L. Scott - Delanson NY, US
Chengde Wu - Pearland TX, US
Jian Li - The Woodlands TX, US
Qi Chen - Carmel IN, US
E. Radford Decker - Houston TX, US
George W. Holland - Houston TX, US
Jamal M. Kassir - Stafford TX, US
Wen Li - Pearland TX, US
Robert V. Market - Pearland TX, US
Ian L. Scott - Delanson NY, US
Chengde Wu - Pearland TX, US
Jian Li - The Woodlands TX, US
Assignee:
Encysive Pharmaceuticals, Inc. - New York NY
International Classification:
A61K 31/4412
US Classification:
514352, 514345, 514349, 546183, 546290, 546296, 546297
Abstract:
A method for the inhibition of the binding of αβintegrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which αβis involved.
Hepatitis C Virus Inhibitors
View pageUS Patent:
8138215, Mar 20, 2012
Filed:
May 14, 2010
Appl. No.:
12/780415
Inventors:
Omar D. Lopez - Wallingford CT, US
Qi Chen - Norwalk CT, US
Makonen Belema - North Haven CT, US
Qi Chen - Norwalk CT, US
Makonen Belema - North Haven CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4174
C07D 233/64
C07D 233/64
US Classification:
514397, 5483131
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
View pageUS Patent:
8377980, Feb 19, 2013
Filed:
Dec 1, 2010
Appl. No.:
12/957512
Inventors:
Makonen Belema - North Haven CT, US
Jeffrey Lee Romine - Meriden CT, US
Van N. Nguyen - Meriden CT, US
Gan Wang - Wallingford CT, US
Omar D. Lopez - Wallingford CT, US
Denis R. St. Laurent - Newington CT, US
Qi Chen - Stamford CT, US
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Piyasena Hewawasam - Middletown CT, US
Ningning Xu - Wallingford CT, US
Nicholas A. Meanwell - East Hampton CT, US
John A. Easter - East Hampton CT, US
Michael J. Smith - Somerset NJ, US
Jeffrey Lee Romine - Meriden CT, US
Van N. Nguyen - Meriden CT, US
Gan Wang - Wallingford CT, US
Omar D. Lopez - Wallingford CT, US
Denis R. St. Laurent - Newington CT, US
Qi Chen - Stamford CT, US
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Piyasena Hewawasam - Middletown CT, US
Ningning Xu - Wallingford CT, US
Nicholas A. Meanwell - East Hampton CT, US
John A. Easter - East Hampton CT, US
Michael J. Smith - Somerset NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4178
C07D 233/64
C07D 233/64
US Classification:
514397, 5483131
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Carboxylic Acid Derivatives That Inhibit The Binding Of Integrins To Their Receptors
View pageUS Patent:
20040063955, Apr 1, 2004
Filed:
Oct 9, 2001
Appl. No.:
09/973142
Inventors:
Ronald Biediger - Houston TX, US
Qi Chen - Carmel IN, US
E. Decker - Houston TX, US
George Holland - Houston TX, US
Jamal Kassir - Stafford TX, US
Wen Li - Pearland TX, US
Robert Market - Pearland TX, US
Ian Scott - Delanson NY, US
Chengde Wu - Pearland TX, US
Jian Li - The Woodlands TX, US
Qi Chen - Carmel IN, US
E. Decker - Houston TX, US
George Holland - Houston TX, US
Jamal Kassir - Stafford TX, US
Wen Li - Pearland TX, US
Robert Market - Pearland TX, US
Ian Scott - Delanson NY, US
Chengde Wu - Pearland TX, US
Jian Li - The Woodlands TX, US
International Classification:
C07D211/40
C07D211/56
C07D211/54
C07D211/56
C07D211/54
US Classification:
546/216000, 546/223000, 546/237000
Abstract:
A method for the inhibition of the binding of integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which is involved.
Hepatitis C Virus Inhibitors
View pageUS Patent:
20100249190, Sep 30, 2010
Filed:
Mar 25, 2010
Appl. No.:
12/731935
Inventors:
Omar D. Lopez - Wallingford CT, US
Qi Chen - Norwalk CT, US
Makonen Belema - North Haven CT, US
Lawrence G. Hamann - North Grafton MA, US
Qi Chen - Norwalk CT, US
Makonen Belema - North Haven CT, US
Lawrence G. Hamann - North Grafton MA, US
International Classification:
A61K 31/454
C07D 403/14
A61K 31/4178
A61P 31/14
C07D 401/14
C07D 413/14
A61K 31/422
C07D 403/14
A61K 31/4178
A61P 31/14
C07D 401/14
C07D 413/14
A61K 31/422
US Classification:
514326, 5483131, 514397, 546210, 548236, 514374
Abstract:
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Hepatitis C Virus Inhibitors
View pageUS Patent:
20110274648, Nov 10, 2011
Filed:
Nov 4, 2010
Appl. No.:
12/939778
Inventors:
Rico Lavoie - Candiac, CA
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Makonen Belema - North Haven CT, US
Omar D. Lopez - Wallingford CT, US
Qi Chen - Stamford CT, US
Gan Wang - Wallingford CT, US
Piyasena Hewawasam - Middletown CT, US
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Makonen Belema - North Haven CT, US
Omar D. Lopez - Wallingford CT, US
Qi Chen - Stamford CT, US
Gan Wang - Wallingford CT, US
Piyasena Hewawasam - Middletown CT, US
International Classification:
A61K 31/4184
C07D 401/14
A61K 31/4545
A61K 31/437
A61K 31/4985
A61K 31/4178
A61K 31/4709
C07D 471/04
A61K 31/4375
C07D 413/14
A61K 31/5377
A61K 38/21
A61K 31/7056
A61K 38/20
A61K 31/713
A61P 31/14
C07D 403/14
C07D 401/14
A61K 31/4545
A61K 31/437
A61K 31/4985
A61K 31/4178
A61K 31/4709
C07D 471/04
A61K 31/4375
C07D 413/14
A61K 31/5377
A61K 38/21
A61K 31/7056
A61K 38/20
A61K 31/713
A61P 31/14
C07D 403/14
US Classification:
424 852, 5483054, 514394, 5483061, 546187, 514316, 546118, 514303, 544350, 514249, 5483131, 514397, 546173, 514306, 544353, 546122, 514300, 544 79, 5142322, 424 854, 514 43, 424 857, 514 44 A
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
View pageUS Patent:
20110281910, Nov 17, 2011
Filed:
Nov 9, 2010
Appl. No.:
12/942183
Inventors:
Rico Lavoie - Candiac, CA
John A. Bender - Middletown CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Carol Bachand - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Qi Chen - Stamford CT, US
Makonen Belema - North Haven CT, US
John F. Kadow - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
John A. Bender - Middletown CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Carol Bachand - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Qi Chen - Stamford CT, US
Makonen Belema - North Haven CT, US
John F. Kadow - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
International Classification:
A61K 31/4178
C07D 417/14
C07D 413/14
C07D 403/14
A61P 31/14
C07D 407/14
A61K 31/427
A61K 31/422
A61K 31/4545
C07D 409/14
C07D 401/14
C07D 417/14
C07D 413/14
C07D 403/14
A61P 31/14
C07D 407/14
A61K 31/427
A61K 31/422
A61K 31/4545
C07D 409/14
C07D 401/14
US Classification:
514316, 5483131, 548204, 548236, 546187, 514397, 514365, 514374
Abstract:
This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Hepatitis C Virus Inhibitors
View pageUS Patent:
20120195857, Aug 2, 2012
Filed:
Aug 4, 2011
Appl. No.:
13/198529
Inventors:
Makonen Belema - North Haven CT, US
Pothukanuri Srinivasu - Bangalore, IN
John A. Bender - Middletown CT, US
Omar D. Lopez - Wallingford CT, US
Qi Chen - Stamford CT, US
Richard A. Rampulla - Flemington NJ, US
Samayamunthula Venkata Satya Arun Kumar Gupta - Bangalore, IN
Nicholas A. Meanwell - East Hampton CT, US
Pothukanuri Srinivasu - Bangalore, IN
John A. Bender - Middletown CT, US
Omar D. Lopez - Wallingford CT, US
Qi Chen - Stamford CT, US
Richard A. Rampulla - Flemington NJ, US
Samayamunthula Venkata Satya Arun Kumar Gupta - Bangalore, IN
Nicholas A. Meanwell - East Hampton CT, US
International Classification:
A61K 31/4178
C07D 413/14
A61K 31/422
C07D 417/14
A61K 31/433
A61P 31/14
A61K 31/5025
A61K 31/7056
A61K 38/21
A61K 38/48
A61K 38/44
A61K 38/46
C07D 403/14
C07D 487/04
C07D 413/14
A61K 31/422
C07D 417/14
A61K 31/433
A61P 31/14
A61K 31/5025
A61K 31/7056
A61K 38/21
A61K 38/48
A61K 38/44
A61K 38/46
C07D 403/14
C07D 487/04
US Classification:
424 857, 5483131, 514397, 5483121, 548235, 514374, 548134, 514362, 544349, 514249, 514 43, 424 854, 424 9467, 424 9464, 424 945, 424 946, 514 43
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.